Tinatin Alaverdashvili, Radiation Oncology Resident at the Todua Clinic, shared a post on LinkedIn:
“Proud to share that our article has just been published in Clinical and Translational Oncology:
“Global perspective on implementing ultra‑hypofractionated radiation therapy in breast cancer: a survey‑based analysis”
- This international survey of 89 radiation oncologists across 24 countries sheds light on the global adoption and perceptions of ultra‑hypofractionated radiotherapy (UHF‑RT) in breast cancer.
- While 81% of respondents have used UHF for at least some patients, moderate hypofractionation remains the most common approach worldwide.
- Major barriers to wider implementation include limited clinical guidelines, insufficient training, infrastructure constraints, and reimbursement challenges.
- Importantly, nearly 53% of respondents anticipate UHF becoming the standard of care within five years, highlighting a global trend toward shorter, more convenient, and cost-effective treatment schedules without compromising patient outcomes.
I am sincerely grateful to all colleagues who participated in our survey and contributed to this work.
Special thanks to Prof. Federico Waisberg for his invaluable support in distributing the survey.
Above all, my deepest thanks go to Prof. Philip Poortmans and Prof. Angel Montero-Luis, whose leadership and expertise in this field are exceptional. It is a true honour to have my name alongside theirs.”
Title: Global perspective on implementing ultra-hypofractionated radiation therapy in breast cancer: a survey-based analysis
Authors: Tinatin Alaverdashvili, Angel Montero, Philip Poortmans
Read the Full Article.
More posts featuring Tinatin Alaverdashvili on OncoDaily.